Exosens Shares Drop by 1.81% Yet Maintain a +41% Annual Gain
The French specialist in night vision and imaging technologies for defense continues its decline at midday. The stock has another session in the red, following a bullish streak marked at the end of May. However, the annual momentum remains very strong.
The Stock Falls Below the MM50 and Erases Part of May's Rebound
Exosens shares are down 1.81% at €62.25, in a SBF 120 that has fallen by 0.36%. The stock is eroding again after peaking at the end of May above €66. The price is now slightly below the MM50 (€63.19, a gap of -1.49%) and at the level of the MM20 (€62.18).
The RSI at 49 indicates a neutral configuration, with no signs of seller exhaustion. The decline remains contained over short horizons (-4.82% over the week, -4.01% over a month), but the annual performance is still strong at +41%, supported by a price that remains 17.65% above the MM200 (€52.91). The technical support identified at €56.45 remains distant, which gives the stock some margin before considering a return to the lower end of the channel.
A Continuous Flow of Industrial Announcements in Defense and Space
The operational context remains favorable for the group, with no new press release today. At the end of May, Exosens joined the European SPIRIT project on infrared detection, an initiative aimed at structuring a European supply chain in defense technologies. A few days earlier, its Micro Pore optics were deployed on ESA's Smile mission, launched on May 19.
On May 21, the group also announced a doubling of its production capacity for cooled infrared cameras by 2026, to meet demand for long-range anti-drone systems. This flurry of announcements had fueled the rally that drove the stock to a peak beyond €66.
The current consolidation appears to be a technical digestion of this movement. The next reference point for the stock is at the MM50 level of €63.19, whose recovery could validate the hypothesis of a return to bullish dynamics.
